Try our Advanced Search for more refined results
September 20, 2017
Track this case
Other Statutes: Anti-Trust
J. CURTIS JOYNER
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.Additional or older documents may be available in Pacer.
Pfizer Inc. has credibly shown that Johnson & Johnson may have flouted antitrust laws by coercing health insurers into not covering biosimilar versions of biologic Remicade, a Pennsylvania federal judge said in a ruling released Friday.
Already a subscriber? Click here to login